Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Efficacy at 2 Weeks of Duac® Fixed Dose Combination Gel in Treatment of Facial Acne Vulgaris in Japanese Subjects

NCT02557399 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02557399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02557399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Efficacy at 2 Weeks of Duac® Fixed Dose Combination Gel in Treatment of Facial Acne Vulgaris in Japanese Subjects
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
October 7, 2015
Completion date
February 17, 2016
Enrollment
350 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris